Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Aprea Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues14.213.4
            Revenue growth6.0% 
Cost of goods sold16.515.9
Gross profit-2.3-2.5
            Gross margin-16.2%-18.4%
General and administrative2.32.5
EBIT-16.5-15.9
            EBIT margin-116.2%-118.4%
Pre-tax income-15.5-15.2
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-15.5-15.2
            Net margin-109.4%-113.4%
 
Diluted EPS($13.45)($13.17)
Shares outstanding (diluted)1.21.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy